Update on digoxin therapy in congestive heart failure

被引:0
作者
Haji, SA [1 ]
Movahed, A [1 ]
机构
[1] E Carolina Univ, Sch Med, Dept Med, Cardiol Sect, Greenville, NC 27858 USA
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Congestive heart failure is a progressive disease with significant morbidity and mortality. Despite advances in the prevention and treatment of cardiovascular diseases, the incidence and prevalence of congestive heart failure have increased in recent years. Contributing factors include increased survival in patients with coronary artery disease (especially myocardial infarction), an aging population and significant advances in the control of other potentially lethal diseases. New and existing agents, including angiotensin-converting enzyme inhibitors, beta blockers and, more recently, spironolactone, are being used increasingly to prolong life in patients with heart failure. Although digoxin has been used to treat heart failure for more than 200 years, its role in patients with congestive heart failure and sinus rhythm is still debatable. Over the past decade, digoxin has received renewed attention because of recognition of its neurohormonal effect and the successful use of lower dosages. In recent trials, digoxin has been shown to reduce morbidity associated with congestive heart failure but to have no demonstrable effect on survival. The goal of digoxin therapy in patients with congestive heart failure is to improve quality of life by reducing symptoms and preventing hospitalizations.
引用
收藏
页码:409 / 416
页数:8
相关论文
共 39 条
[1]   CAPTOPRIL VERSUS DIGOXIN IN MILD MODERATE CHRONIC HEART-FAILURE - A CROSSOVER STUDY [J].
ALICANDRI, C ;
FARIELLO, R ;
BONI, E ;
ZANINELLI, A ;
CASTELLANO, M ;
BESCHI, M ;
ROSEI, EA ;
MUIESAN, G .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1987, 9 :S61-S67
[2]   EFFECT OF DIGITALIS TREATMENT ON SURVIVAL AFTER ACUTE MYOCARDIAL-INFARCTION [J].
BIGGER, JT ;
FLEISS, JL ;
ROLNITZKY, LM ;
MERAB, JP ;
FERRICK, KJ .
AMERICAN JOURNAL OF CARDIOLOGY, 1985, 55 (06) :623-630
[3]   THE ADRENERGIC NERVOUS-SYSTEM IN HEART-FAILURE [J].
BRISTOW, MR .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 311 (13) :850-851
[4]  
Cauffield JS, 1997, AM FAM PHYSICIAN, V56, P495
[5]  
CAUFFIELD JS, 1997, AM FAM PHYSICIAN, V56, P509
[6]   STUDIES ON DIGITALIS .16. EFFECTS ON MYOCARDIAL OXYGEN CONSUMPTION [J].
COVELL, JW ;
BRAUNWALD, E ;
ROSS, J ;
SONNENBLICK, EH .
JOURNAL OF CLINICAL INVESTIGATION, 1966, 45 (10) :1535-+
[7]   MAINTENANCE DIGOXIN IN ELDERLY PATIENTS [J].
DALL, JLC .
BRITISH MEDICAL JOURNAL, 1970, 2 (5711) :705-&
[8]   Medical therapy can improve the biological properties of the chronically failing heart - A new era in the treatment of heart failure [J].
Eichhorn, EJ ;
Bristow, MR .
CIRCULATION, 1996, 94 (09) :2285-2296
[9]   Cardiac sympathetic nerve function in congestive heart failure [J].
Eisenhofer, G ;
Friberg, P ;
Rundqvist, B ;
Quyyumi, AA ;
Lambert, G ;
Kaye, DM ;
Kopin, IJ ;
Goldstein, DS ;
Esler, MD .
CIRCULATION, 1996, 93 (09) :1667-1676
[10]   EFFECTS OF INCREASING MAINTENANCE DOSE OF DIGOXIN ON LEFT-VENTRICULAR FUNCTION AND NEUROHORMONES IN PATIENTS WITH CHRONIC HEART-FAILURE TREATED WITH DIURETICS AND ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS [J].
GHEORGHIADE, M ;
HALL, VB ;
JACOBSEN, G ;
ALAM, M ;
ROSMAN, H ;
GOLDSTEIN, S .
CIRCULATION, 1995, 92 (07) :1801-1807